COVID-19 convalescent plasma from Norwegian blood donors

Tidsskr Nor Laegeforen. 2022 Jun 13;142(9). doi: 10.4045/tidsskr.22.0057. Print 2022 Jun 14.
[Article in English, Norwegian]
No abstract available

Plain language summary

The collection and use of convalescent plasma to treat COVID-19 has taught us important lessons about the organisation, testing and selection of blood donors and patients. This is knowledge that can be used in the next pandemic.

MeSH terms

  • Antibodies, Viral
  • Blood Donors*
  • COVID-19* / therapy
  • Humans
  • Immunization, Passive
  • SARS-CoV-2

Substances

  • Antibodies, Viral

Supplementary concepts

  • COVID-19 serotherapy